241 – 250 of 354
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer
(
- Contribution to journal › Article
-
Mark
Standardization of Two Immunoassays for Human Glandular Kallikrein 2.
(
- Contribution to journal › Article
-
Mark
Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA Committee
(
- Contribution to journal › Article
-
Mark
Biology of prostate-specific antigen.
(
- Contribution to journal › Article
-
Mark
Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen
(
- Contribution to journal › Article
-
Mark
Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer
(
- Contribution to journal › Article
-
Mark
Percent-free prostate specific antigen is elevated in men on haemodialysis or peritoneal dialysis treatment.
(
- Contribution to journal › Article
-
Mark
Free-to-total prostate-specific antigen ratio as a predictor of non-organ-confined prostate cancer (stage pT3)
(
- Contribution to journal › Article
-
Mark
Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantation.
(
- Contribution to journal › Article
-
Mark
Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening
(
- Contribution to journal › Article